Skip to main content
Scienture Holdings, Inc. logo

Scienture Holdings, Inc. — Investor Relations & Filings

Ticker · SCNX ISIN · US89846A2078 US Manufacturing
Open in API
Filings indexed 495 across all filing types
Latest filing 2020-01-24 Capital/Financing Update
Country US United States of America
Listing US SCNX

About Scienture Holdings, Inc.

https://www.trxadehealth.com/

Scienture Holdings, Inc. is a holding company that operates through its subsidiaries, including Scienture, LLC and Integra Pharma Solutions, LLC. The company functions as an integrated pharmaceutical and health services provider focused on the development, commercialization, and distribution of novel specialty products. A key therapeutic area includes treatments for central nervous system disorders. Scienture Holdings aims to enhance value for patients and physicians by addressing the needs of underserved populations and bridging gaps in treatment delivery systems to improve healthcare outcomes. The company also provides a web-based purchasing platform for transactions.

Recent filings

Filing Released Lang Actions
Capital/Financing Update 2020
Capital/Financing Update Classification · 95% confidence The document is a Form S-1/A (Amendment No. 1) registration statement filed with the SEC under the Securities Act of 1933. It is a registration statement for a public offering of common stock by Trxade Group, Inc. The text includes detailed information about the offering, underwriting, reverse stock split, risk factors, use of proceeds, capitalization, dilution, management discussion and analysis, and other disclosures typical of a registration statement prospectus. This is not an annual or quarterly report, nor an earnings release or other types of filings. It is a capital raising document related to an initial or follow-on public offering. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains the full registration statement text, not just an announcement or certification, so it is not RPA or RNS. Confidence is high due to clear identification of Form S-1/A and detailed offering information.
2020-01-24 English
Regulatory Filings 2019
Regulatory Filings Classification · 90% confidence The provided document text appears to be encoded or encrypted and does not contain any readable content, keywords, regulatory headers, form names, fiscal period dates, or document titles that would allow identification of a specific filing type. The text is approximately 15,000 characters long, which is substantial, but without meaningful content, it cannot be classified as a financial report or any specific filing type. Given the lack of identifiable information and the fallback rule, the document should be classified as a Regulatory Filing (RNS).
2019-12-23 English
Capital/Financing Update 2019
Capital/Financing Update Classification · 95% confidence The document is a Form S-1 Registration Statement filed with the SEC, dated December 16, 2019, for Trxade Group, Inc. It is a registration statement under the Securities Act of 1933, used for initial public offerings or other securities offerings. The text includes detailed information about the offering, company background, risk factors, use of proceeds, capitalization, management discussion and analysis, and other disclosures typical of an S-1 filing. This is not an annual report, earnings release, or any other type of financial report but a capital markets filing related to a securities offering. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains the full registration statement, not just an announcement or notice, so it is not RPA or RNS. Confidence is high given the clear identification of the form and content.
2019-12-16 English
Director's Dealing 2019
Director's Dealing
2019-11-22 English
Regulatory Filings 2019
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The text indicates it is a short filing (3133 characters) announcing a press release about the launch of "Bonum Health Hubs". It includes an exhibit which is the press release itself. There are no financial statements or detailed financial data included. The document is not an annual or quarterly report, nor an earnings release. It is not a certification or officer attestation. The document is an announcement of an event via a press release, typical of an 8-K filing. Given the content and length, this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories.
2019-11-21 English
Board/Management Information 2019
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content specifically details the resignation of a board member, the appointment of a new board member, the formation of a new committee, and the appointment of committee members. There are no financial statements or earnings data included. The primary focus is on changes in the company's board of directors and governance structure. This matches the description of Board/Management Information (MANG). The document length is sufficient and contains detailed biographical and committee information, confirming it is not a brief announcement or a certification. Therefore, the correct classification is MANG with high confidence.
2019-11-20 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.